SAN FRANCISCO, Nov. 26 - Incyte Genomics said on Monday that co-founder Roy Whitfield has been replaced as CEO by Paul Friedman, formerly the president of DuPont Pharmaceuticals Research Laboratories, in a move that underscores Incyte's intent to move swiftly from a genomics database provider to a profitable drug developer.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.